Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.

Philip Mease,Laura C Coates,Philip S Helliwell,Mykola Stanislavchuk,Anna Rychlewska-Hanczewska,Anna Dudek,Walid Abi-Saab,Chantal Tasset,Luc Meuleners,Pille Harrison,Robin Besuyen,Annegret Van der Aa,Neelufar Mozaffarian,Joy M Greer,Rebecca Kunder,Filip Van den Bosch,Dafna D Gladman

Lancet (London, England)（2018）

Cited 170|Views9
No score
Abstract
Galapagos and Gilead Sciences.
More
Translated text
Key words
active psoriatic arthritis,psoriatic arthritis,selective janus kinase,filgotinib,placebo-controlled
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined